Anti-Hypertensive Drugs Market Growth, Analysis Report, Share, Trends and Overview 2022-2028

The global anti-hypertension drugs market is estimated to grow at a CAGR of over 4% during the forecast period. Hypertension is a common condition among patients with diabetes. Hence, the adoption of anti-hypertensive is high among the diabetic population for the treatment of hypertension. Hence, the increased diabetic population coupled with the adoption of anti-hypertensive drugs is anticipated to drive the anti-hypertensive drug market industry significantly. Additionally, Angiotensin-converting enzyme (ACE) inhibitors manufactured by companies such as Novartis AG and Pfizer Inc. are the most used anti-hypertensive drugs by diabetic patients.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/anti-hypertensive-drugs-market

Furthermore, hypertension is a major risk factor for patients suffering from conditions such as atherosclerotic cardiovascular disease (ASCVD), heart failure, and microvascular complications. ASCVD is considered to be a leading cause of morbidity and mortality in patients with diabetes. In recent years, numerous studies have shown that anti-hypertensive drug therapy can aid in significantly reducing ASCVD events. Along with ASCVD, anti-hypertensive drugs can aid in conditions such as heart failure, and microvascular complications in diabetic patients. Hence, the positive effects of anti-hypertensive drugs on ASCVD and other conditions are anticipated to drive the anti-hypertensive drugs market growth considerably during the forecast period.

Additionally, anti-hypertensive drug-based treatment can be given to the patient either as monotherapy or in suitable combinations. In addition to this, anti-hypertensive drugs also shows good outcomes when used for non pharmacological treatment such as low salt diet, weight loss, exercise, in diabetic patients which impact the anti-hypertensive drug market. Moreover, various government organizations across the globe are involved in the study of hypertension in diabetic patients that have also suggested the use of anti-hypertensive drugs in their guidelines, which in turn, is expected to expand the anti-hypertensive drug market size.

For instance, in the guidelines from European Society of Hypertension (ESH) and European Society of Cardiology, the use of drugs such as thiazide diuretics, ?-blockers, calcium channel blockers (CCBs), ACEis and angiotensin II receptor blockers (ARBs) are recommended for the initiation and maintenance of hypertension in diabetic patients. The drugs recommended in guidelines are anti-hypertensive drugs that are preferred to be used mostly in diabetic patients. Therefore, the guidelines from ESH and European Society of Cardiology, regarding the use of anti-hypertensive drugs are expected to drive the anti-hypertensive drugs market growth significantly during the forecasted period. 

Anti-Hypertensive Drugs Market- Segmentation

By Drug Class

·         Thiazide Diuretics

·         Calcium Channel Blockers

·         ACE Inhibitors

·         Angiotensin II Receptor Antagonists (ARBS)

·         Beta-Blockers

·         Others

A full report of Global Anti-Hypertensive Drugs Market is available at: https://www.omrglobal.com/industry-reports/anti-hypertensive-drugs-market

Global Anti-Hypertensive Drugs Market– Segment by Region

North America          

·         United States

·         Canada

Europe

·         Germany

·         United Kingdom

·         France

·         Spain

·         Italy

·         Rest of Europe

Asia-Pacific   

·         China

·         Japan

·         India

·         Rest of Asia-Pacific

Rest of the World

·         Middle East & Africa

·         Latin America

Company Profiles

·         AstraZeneca PLC

·         Bayer AG

·         Boehringer Ingelheim International GmbH

·         Daiichi Sankyo Co., Ltd.

·         Johnson & Johnson Services, Inc.

·         Lupin Ltd.

·         Merck KGaA

·         Noden Pharma DAC

·         Novartis International AG

·         Pfizer Inc.

·         Ranbaxy Laboratories Ltd.

·         Renata Ltd.

·         Sanofi S.A.

·         Sun Pharmaceuticals LLC

·         Takeda Pharmaceutical Company Ltd.

·         Teva Pharmaceutical Industries Ltd.

·         Unichem Laboratories Ltd.

·         United Therapeutics Corp.

 

Reasons to Buying From us –

1.       We cover more than 15 major industries, further segmented into more than 90 sectors.

2.       More than 120 countries are for analysis.

3.       Over 100+ paid data sources mined for investigation.

4.       Our expert research analysts answer all your questions before and after purchasing your report.

 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

 

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research